QNTA Escozine® has already been Proven successfully with 95% -98% Efficacy to 8,300 Patients since the Polarization Technology Patent was Granted in 2012.
And this recent update conducted on over 500 patients... Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
Lastly,QNTA Escozine® base is a "Natural Compound" from Blue Scorpion Venom not Like those "Synthetic Base" utilize by BioTech/Pharmas and wasting Billions of Dollars for years with very disappointing Efficacy for Cancer Treatments.
The Time and Opportunity to invest in Biotechs is when the pps is still @ groundfloor,Like VXRT NVAX OCGN etc when they were Trading @ Buck or under. At their current pps, it's just for daytrading nowadays for atm$.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.